☰

Mridul Mukherji - Publications

Affiliations: 
Pharmaceutical Science University of Missouri - Kansas City, USA 
Area:
Molecular Biology, Biochemistry, Pharmacy
Tree Info Similar researchers PubMed Report error

24/41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Bhattacharya C, Dey AS, Ayon NJ, Gutheil WG, Mukherji M. Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase. Journal of Visualized Experiments : Jove. PMID 30371677 DOI: 10.3791/57798  0.325
2017 Jaiswal M, Bhar S, Vemula H, Prakash S, Ponnaluri VK, Gutheil WG, Mukherji M. Convenient expression, purification and quantitative liquid chromatography-tandem mass spectrometry-based analysis of TET2 5-methylcytosine demethylase. Protein Expression and Purification. PMID 28188826 DOI: 10.1016/J.Pep.2017.02.003  0.762
2016 Subhani S, Vavilala DT, Mukherji M. HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies. Angiogenesis. PMID 27146677 DOI: 10.1007/S10456-016-9510-0  0.778
2014 Vavilala DT, Reddy S, Sachchidanand, Prakash S, Ponnaluri VKC, Kumar A, Mukherji M. Prohexadione, a plant growth regulator, inhibits histone lysine demethylases and modulates epigenetics. Toxicology Reports. 1: 1152-1161. PMID 28962325 DOI: 10.1016/J.Toxrep.2014.10.026  0.767
2014 Vavilala DT, Ponnaluri VK, Kanjilal D, Mukherji M. Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases. Plos One. 9: e113717. PMID 25422886 DOI: 10.1371/Journal.Pone.0113717  0.77
2014 Vadlapatla RK, Vadlapudi AD, Pal D, Mukherji M, Mitra AK. Ritonavir inhibits HIF-1α-mediated VEGF expression in retinal pigment epithelial cells in vitro. Eye (London, England). 28: 93-101. PMID 24202050 DOI: 10.1038/Eye.2013.240  0.489
2014 Vavilala DT, Ponnaluri VKC, Kanjilal D, Mukherji M. Immunofluorescence analysis to evaluate translocation of HIF-1 α from cytoplasm to nucleus. Plos One. DOI: 10.1371/Journal.Pone.0113717.G003  0.731
2014 Vavilala DT, Reddy S, Sachchidanand, Prakash S, Ponnaluri VKC, Kumar A, Mukherji M. Prohexadione, a plant growth regulator, inhibits histone lysine demethylases and modulates epigenetics Toxicology Reports. 1: 1152-1161. DOI: 10.1016/j.toxrep.2014.10.026  0.754
2013 Vavilala DT, O'Bryhim BE, Ponnaluri VK, White RS, Radel J, Symons RC, Mukherji M. Honokiol inhibits pathological retinal neovascularization in oxygen-induced retinopathy mouse model. Biochemical and Biophysical Research Communications. 438: 697-702. PMID 23921228 DOI: 10.1016/J.Bbrc.2013.07.118  0.769
2013 Ponnaluri VK, Vavilala DT, Prakash S, Mukherji M. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas. Biochemical and Biophysical Research Communications. 438: 71-7. PMID 23872148 DOI: 10.1016/J.Bbrc.2013.07.028  0.753
2013 Vadlapatla RK, Vadlapudi AD, Ponnaluri VK, Pal D, Mukherji M, Mitra AK. Molecular expression and functional activity of efflux and influx transporters in hypoxia induced retinal pigment epithelial cells. International Journal of Pharmaceutics. 454: 444-52. PMID 23827654 DOI: 10.1016/J.Ijpharm.2013.06.044  0.772
2013 Ponnaluri VK, Maciejewski JP, Mukherji M. A mechanistic overview of TET-mediated 5-methylcytosine oxidation. Biochemical and Biophysical Research Communications. 436: 115-20. PMID 23727577 DOI: 10.1016/J.Bbrc.2013.05.077  0.759
2013 Vavilala DT, Vadlapatla RK, Ponnaluri VKC, Prakash S, Mukherji M. Berberine modulates epigenetics via inhibition of hypoxia-induced histone lysine demethylases expression Drug Development Research. 74: 15-22. DOI: 10.1002/Ddr.21051  0.819
2012 Vavilala DT, Ponnaluri VK, Vadlapatla RK, Pal D, Mitra AK, Mukherji M. Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases. Biochemical and Biophysical Research Communications. 422: 369-74. PMID 22580280 DOI: 10.1016/J.Bbrc.2012.04.143  0.786
2011 Ponnaluri VK, Vadlapatla RK, Vavilala DT, Pal D, Mitra AK, Mukherji M. Hypoxia induced expression of histone lysine demethylases: implications in oxygen-dependent retinal neovascular diseases. Biochemical and Biophysical Research Communications. 415: 373-7. PMID 22037463 DOI: 10.1016/J.Bbrc.2011.10.075  0.784
2011 Bobba S, Ponnaluri VK, Mukherji M, Gutheil WG. Microtiter plate-based assay for inhibitors of penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 55: 2783-7. PMID 21402836 DOI: 10.1128/Aac.01327-10  0.739
2011 Ponnaluri VK, Vavilala DT, Mukherji M. Studies on substrate specificity of Jmjd2a-c histone demethylases. Biochemical and Biophysical Research Communications. 405: 588-92. PMID 21266164 DOI: 10.1016/J.Bbrc.2011.01.073  0.731
2009 Ponnaluri VK, Vavilala DT, Putty S, Gutheil WG, Mukherji M. Identification of non-histone substrates for JMJD2A-C histone demethylases. Biochemical and Biophysical Research Communications. 390: 280-4. PMID 19799855 DOI: 10.1016/J.Bbrc.2009.09.107  0.745
2006 Mukherji M, Bell R, Supekova L, Wang Y, Orth AP, Batalov S, Miraglia L, Huesken D, Lange J, Martin C, Sahasrabudhe S, Reinhardt M, Natt F, Hall J, Mickanin C, et al. Genome-wide functional analysis of human cell-cycle regulators. Proceedings of the National Academy of Sciences of the United States of America. 103: 14819-24. PMID 17001007 DOI: 10.1073/Pnas.0604320103  0.332
2005 Mukherji M. Phosphoproteomics in analyzing signaling pathways. Expert Review of Proteomics. 2: 117-28. PMID 15966857 DOI: 10.1586/14789450.2.1.117  0.323
2001 Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107: 43-54. PMID 11595184 DOI: 10.1016/S0092-8674(01)00507-4  0.404
2001 Mukherji M, Chien W, Kershaw NJ, Clifton IJ, Schofield CJ, Wierzbicki AS, Lloyd MD. Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease. Human Molecular Genetics. 10: 1971-82. PMID 11555634 DOI: 10.1093/Hmg/10.18.1971  0.313
2001 Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (New York, N.Y.). 292: 468-72. PMID 11292861 DOI: 10.1126/Science.1059796  0.355
2001 Mukherji M, Kershaw NJ, MacKinnon CH, Clifton IJ, Wierzbicki AS, Schofield CJ, Lloyd MD. ‘Chemical co-substrate rescue’ of phytanoyl-CoA 2-hydroxylase mutants causing Refsum’s Disease Chemical Communications. 2001: 972-973. DOI: 10.1039/B101039P  0.32
Low-probability matches (unlikely to be authored by this person)
2005 Searls T, Butler D, Chien W, Mukherji M, Lloyd MD, Schofield CJ. Studies on the specificity of unprocessed and mature forms of phytanoyl-CoA 2-hydroxylase and mutation of the iron binding ligands. Journal of Lipid Research. 46: 1660-7. PMID 15930519 DOI: 10.1194/Jlr.M500034-Jlr200  0.299
2018 Guan Y, Greenberg EF, Hasipek M, Hirsch CM, Graham AC, Radivoyevitch T, Chen S, Liu X, Visconte V, You D, Negoro E, Przychodzen BP, Makishima H, Nazha A, Gackowski D, ... ... Mukherji M, et al. Modulation of TET2 Activity By Ascorbic Acid and Factors Affecting Lysine Acetylation Blood. 132: 4346-4346. DOI: 10.1182/Blood-2018-99-119712  0.291
2006 Mukherji M, Brill LM, Ficarro SB, Hampton GM, Schultz PG. A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways. Biochemistry. 45: 15529-40. PMID 17176074 DOI: 10.1021/Bi060971C  0.286
2002 Lipscomb SJ, Lee HJ, Mukherji M, Baldwin JE, Schofield CJ, Lloyd MD. The role of arginine residues in substrate binding and catalysis by deacetoxycephalosporin C synthase. European Journal of Biochemistry / Febs. 269: 2735-9. PMID 12047382 DOI: 10.1046/J.1432-1033.2002.02945.X  0.284
2001 Kershaw NJ, Mukherji M, MacKinnon CH, Claridge TD, Odell B, Wierzbicki AS, Lloyd MD, Schofield CJ. Studies on phytanoyl-CoA 2-hydroxylase and synthesis of phytanoyl-coenzyme A. Bioorganic & Medicinal Chemistry Letters. 11: 2545-8. PMID 11549466 DOI: 10.1016/S0960-894X(01)00494-2  0.279
2002 Mukherji M, Kershaw NJ, Schofield CJ, Wierzbicki AS, Lloyd MD. Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid. Chemistry & Biology. 9: 597-605. PMID 12031666 DOI: 10.1016/S1074-5521(02)00139-4  0.279
2004 Brill LM, Salomon AR, Ficarro SB, Mukherji M, Stettler-Gill M, Peters EC. Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Analytical Chemistry. 76: 2763-72. PMID 15144186 DOI: 10.1021/Ac035352D  0.268
2003 Mukherji M, Schofield CJ, Wierzbicki AS, Jansen GA, Wanders RJ, Lloyd MD. The chemical biology of branched-chain lipid metabolism. Progress in Lipid Research. 42: 359-76. PMID 12814641 DOI: 10.1016/S0163-7827(03)00016-X  0.267
2003 Deiters A, Cropp TA, Mukherji M, Chin JW, Anderson JC, Schultz PG. Adding amino acids with novel reactivity to the genetic code of Saccharomyces cerevisiae. Journal of the American Chemical Society. 125: 11782-3. PMID 14505376 DOI: 10.1021/Ja0370037  0.247
2003 Lloyd MD, Mukherji M, Kershaw NJ, Chien W, Wierzbicki AS, Schofield CJ. Role of phytanoyl-CoA 2-hydroxylase in phytanic acid metabolism. Advances in Experimental Medicine and Biology. 544: 303-4. PMID 14713244 DOI: 10.1007/978-1-4419-9072-3_38  0.239
2015 Nazha A, Meggendorfer M, Nadarajah N, Kneen KE, Radivoyevitch T, Przychodzen B, Makishima H, Patel BJ, Sanikommu SR, Hobson S, Mukherji M, Sekeres MA, Haferlach T, Maciejewski JP. TET 2 Alterations in Myeloid Malignancies, Impact on Clinical Characteristics, Outcome, and Disease Predisposition Blood. 126: 1645-1645. DOI: 10.1182/Blood.V126.23.1645.1645  0.237
2020 Guan Y, Greenberg EF, Hasipek M, Chen S, Liu X, Kerr CM, Gackowski D, Zarakowska E, Radivoyevitch T, Gu X, Willard B, Visconte V, Makishima H, Nazha A, Mukherji M, et al. Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia. Communications Biology. 3: 493. PMID 32895473 DOI: 10.1038/s42003-020-01220-9  0.232
2004 Deiters A, Cropp TA, Summerer D, Mukherji M, Schultz PG. Site-specific PEGylation of proteins containing unnatural amino acids. Bioorganic & Medicinal Chemistry Letters. 14: 5743-5. PMID 15501033 DOI: 10.1016/J.Bmcl.2004.09.059  0.231
2003 Chin JW, Cropp TA, Anderson JC, Mukherji M, Zhang Z, Schultz PG. An expanded eukaryotic genetic code. Science (New York, N.Y.). 301: 964-7. PMID 12920298 DOI: 10.1126/Science.1084772  0.214
2023 Bhattacharya C, Dey AS, Mukherji M. Substrate DNA length regulates the activity of TET 5-methylcytosine dioxygenases. Cell Biochemistry and Function. PMID 37349892 DOI: 10.1002/cbf.3825  0.177
2020 Dey AS, Ayon NJ, Bhattacharya C, Gutheil WG, Mukherji M. Positive/negative ion-switching-based LC-MS/MS method for quantification of cytosine derivatives produced by the TET-family 5-methylcytosine dioxygenases. Biology Methods & Protocols. 5: bpaa019. PMID 33376805 DOI: 10.1093/biomethods/bpaa019  0.156
2010 Rivera-Amill V, Kumar R, Noel RJ, Garcia Y, Rodriguez IV, Martinez M, Sariol CA, Kraiselburd E, Iszard M, Mukherji M, Kumar S, Giavedoni LD, Kumar A. Short communication: Lack of immune response in rapid progressor morphine-dependent and SIV/SHIV-infected rhesus macaques is correlated with downregulation of TH1 cytokines. Aids Research and Human Retroviruses. 26: 919-22. PMID 20672973 DOI: 10.1089/Aid.2010.0012  0.064
Hide low-probability matches.